Parabilis Medicines, Inc.(PBLS)
$29.65-0.37 (-1.23%)
PBLS
Parabilis Medicines, Inc. stock drug pipeline
$29.65
At close:-0.37 (-1.23%)
Want to see PBLS full AI Analyst Report?
Parabilis Medicines, Inc. (PBLS) Drug Pipeline
36 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bevacizumab, Nivolumab, Mfolfox-6, Trifluridine/Tipiracil, Fog-001, Opdivo, Avastin | Colorectal Cancer, Solid Tumor, Cancer, Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Locally Advanced Solid Tumor, Metastatic Cancer, Endometrial Carcinoma, Microsatellite Stable Colorectal Cancer, Hcc, Desmoid, Familial Adenomatous Polyposis (Fap), Microsatellite Instability-High Colorectal Cancer, Wnt Pathway, Adamantinomatous Craniopharyngioma | phase1AndPhase2 | Recruiting | FOG-001 in Locally Advanced or Metastatic Solid Tumors | May 19, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bevacizumab, Nivolumab, Mfolfox-6, Trifluridine/Tipiracil, Fog-001, Opdivo, Avastin | phase1AndPhase2 | Colorectal Cancer, Solid Tumor, Cancer, Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Locally Advanced Solid Tumor, Metastatic Cancer, Endometrial Carcinoma, Microsatellite Stable Colorectal Cancer, Hcc, Desmoid, Familial Adenomatous Polyposis (Fap), Microsatellite Instability-High Colorectal Cancer, Wnt Pathway, Adamantinomatous Craniopharyngioma | Recruiting | FOG-001 in Locally Advanced or Metastatic Solid Tumors | May 19, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Parabilis Medicines, Inc. (PBLS) have in its pipeline
Parabilis Medicines, Inc. PBLS is currently developing the following drugs: Bevacizumab, Nivolumab, Mfolfox-6, Trifluridine/Tipiracil, Fog-001, Opdivo, Avastin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
